Nayak SK, Khatik GL, Narang R, Chopra HK. DESIGN AND ANTICANCER ACTIVITY PREDICTION OF DIHYROPYRIMIDINONE BASED NOVEL INHIBITORS OF P53-MDM2 INTERACTION. Asian J Pharm Clin Res [Internet]. 2017 Sep. 1 [cited 2024 Apr. 26];10(16):110-6. Available from: https://journals.innovareacademics.in/index.php/ajpcr/article/view/21346